Helicobacter pylori can multiply in autophagic vesicles

January 28, 2009

Helicobacter pylori, a Gram-negative, flagellated, microaerophilic bacterium, can selectively colonize in the human stomach. Its infection is widespread throughout the world, and is present in about 50% of the global human population with 80% in developing countries and 20-50% in industrialized countries. Infection of the stomach with H. pylori induces a local immune response with infiltration of the mucosa by macrophages, neutrophils and lymphocytes.

Although the innate and adaptive immune responses are activated, the bacterium is rarely eliminated and infections can last for decades if left untreated. Most infections are asymptomatic, but overt diseases can occur in 10-20 % of infected individuals. The disease spectrum ranges from gastritis to peptic ulceration disease. A long-term chronic infection will increase the risk to gastric adenocarcinoma and mucosa-associated lymphoid-tissue lymphoma. It has been classified as a class I carcinogen by the WHO. Despite intensive studies, and the award of the 2005 Nobel Prize in Physiology for the discovery of the bacterium H. pylori by Robin Warren and Barry Marshall, our understanding of H. pylori-infection-caused disease is still limited.

H. pylori has evolved several mechanisms to increase its adherence and persistence in the host. In addition, it must also evade immune clearance. Elimination of H. pylori by phagocytes is inefficient because H. pylori exhibits several virulence factors to evade opsonization, retard phagocytosis, and disrupt membrane trafficking and phagosome maturation after internalization of the microorganism.

In the February 2009 issue of Experimental Biology and Medicine researchers at the National Cheng Kung University, Tainan, Taiwan, have reported a novel phenomenon involving autophagosome formation induced by H. pylori infection and subsequent adoption of these autophagic vesicles by H. pylori for replication in macrophages. The fate of H. pylori is dependent on the strains (isolates) as well as the host macrophages used. Several clinical isolates of H. pylori from Taiwanese patients, but not standard strains, can multiply in the double-layered vesicles of macrophages. The senior author, Dr. Huan-Yao Lei stated that "The autophagy induction by H. pylori is not only found in macrophages, but also in dendritic cells and gastric epithelial cells". This new finding has several implications for the life cycle of H. pylori in the host. H. pylori can be considered as a kind of intracellular microorganism because it can invade host cells to undergo replication within the autophagosome. The bacterium's residence inside infected cells not only increases its resistance to antibiotic treatment, but also avoids neutralization by anti-H. pylori antibodies. In view of the critical role of dendritic cells in presenting H. pylori antigen to initiate the immune response, it is possible that H. pylori-infected dendritic cells induce an inadequate immune response to H. pylori infection that might hinder the clearance of this bacterium. Alternatively, the various immunopathogenesis during the H. pylori-caused diseases might be caused by an unbalanced Th-1 or Th2-mediated response post infection. Finally, the micro-heterogeneity of Taiwanese H. pylori isolates used in this study provides an important hint as to why this microorganism causes so broad a spectrum of diseases. Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine stated "This study also has potential implications for new anti-H. pylori drugs that target the enhancement of autophagy. Dr. Lei and his co-workers have provided an important contribution to our understanding of H. pylori infection."

Society for Experimental Biology and Medicine

---

---

	HELICOBACTER PYLORI VANQUISHED : All-natural three-pronged strategy for exterminating H.pylori (More details added!) This ebook is for you, if : • You are looking for a safe, powerful, all-natural, and affordable treatment for H.pylori, as an alternative to the conventional triple therapy • You wish to learn more about H.pylori • You want to avoid the trouble of sifting the internet searching for a natural way to eradicate H.pylori • You are fed up of taking antibiotics to heal H.pylori This ebook has been written so that the reader may know that they have the option of an all-natural, highly effective and affordable treatment. It is the product of an intensive research carried out by the author after he was struck by H.pylori. Like many others, he was skeptical about the potency and effectiveness of an all-natural treatment, and therefore opted for the...
	Helicobacter pylori by Lyudmila Boyanova (Editor) The revolutionary discovery of Helicobacter pylori started a new era in the understanding and management of gastroduodenal diseases. H. pylori is associated with chronic gastritis, peptic ulcers, MALT lymphoma, the pathogenesis of gastric cancer and several extra-gastric diseases. The organism displays an enormous genetic diversity and some strains harbor numerous virulence factors. No vaccines are available yet and increased antibiotic resistance of the bacteria is of growing concern. Many questions about H. pylori pathogenesis, epidemiology, prophylaxis, and treatment remain to be answered. In addition, the role of non-pylori Helicobacter species is becoming a topic of considerable medical interest. This book highlights recent research and provides an up-to-date summary of current...
	Helicobacter Pylori (Deadly Diseases & Epidemics) by Shawna L. Fleming (Author), Edward I. Alcamo (Editor), David Heymann (Editor)
	A Clinician's Guide to Salvage Therapy for Persistent Helicobacter pylori Infection (DOI: 10.3810/hp.2011.02.383) (Hospital Practice) by JTE Multimedia Since its discovery in 1982, Helicobacter pylori has been established as a common cause of gastritis and peptic ulcer disease. H pylori infection is also closely associated with several gastric malignancies and has consequently been designated a human carcinogen. As these associations have become increasingly recognized and pursued, a growing challenge facing today’s clinicians is the management of patients with persistent H pylori despite previous attempts to treat the infection. In developed countries, the most popular treatment regimen remains traditional triple therapy consisting of a proton pump inhibitor, clarithromycin, and amoxicillin for 7 to 14 days. Unfortunately, eradication rates with traditional triple therapy are disappointing, with infection persisting in as many as 25%...
	TOWARD A SIMPLIFIED STRATEGY FOR MANAGING DYSPEPSIA: Use of simple diagnostic tests for Helicobacter pylori can reduce unnecessary investigation in patients ... ulcer disease. (Postgraduate Medicine) by JTE Multimedia Pain or discomfort in the upper abdomen (ie, dyspepsia) accounts for a substantial number of patient visits to primary care physicians. In the United States, the prevalence of dyspeptic symptoms is about 25% (when patients with typical gastroesophageal reflux disease symptoms are excluded), but not all patients with dyspepsia present to a physician (1). Original Publication Date: June 2005
	PEPTIC ULCER AND HELICOBACTER PYLORI: Update on testing and treatment (Postgraduate Medicine) by JTE Multimedia As evidence about the relationship between Helicobacter pylori infection and peptic ulcers accumulates, accurate testing and treatment are becoming increasingly important. However, big questions remain about the best strategies for detecting and managing this infection. In this article, the authors discuss the association between H pylori and peptic ulcer disease, the available tests for detecting the infection, and the latest treatment strategies for effective eradication. Original Publication Date: June 2005
	THE ROLE OF H PYLORI IN GASTROINTESTINAL DISEASE: A guide to identification and eradication (Postgraduate Medicine) by JTE Multimedia Helicobacter pylori, which is responsible for the most common infection worldwide, has been implicated in several gastrointestinal diseases, such as peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue (MALT) lymphoma. In this article, Dr Knigge discusses the unique adaptation of H pylori to the acidic gastric environment and describes diagnostic tests to identify the organism, treatment recommendations, and tools to confirm eradication of infection. Original Publication Date: September 2001
	Helicobacter pylori: Molecular Genetics and Cellular Biology by Yoshio Yamaoka (Editor) Helicobacter pylori is an important human pathogen that infects up to 50% of the human population. As the leading cause of peptic ulcers, gastritis, and gastric cancer worldwide, the organism has been the subject of intensive research to unravel the mysteries of its genetics and cellular biology. In fact, the number of publications in this field has risen dramatically in recent years making it extremely difficult for even the most diligent reader to stay abreast of progress. This book distills the most important cutting-edge findings in the field to produce a timely and comprehensive review. With contributions from leading international helicobacter researchers, topics include: lipopolysaccharides, outer membrane proteins, motility and chemotaxis, type IV secretions systems, metal...
	Helicobacter Pylori: Molecular & Cellular Biology by Mark Achtman (Editor), Sebastian Suerbaum (Editor) An awe-inspiring amount of knowledge has been acquired about Helicobacter pylori biology over the last decade. The diversity of approaches employed by scientists from different fields and the sheer numbers of publications produced make it difficult for even the most diligent reader to stay abreast of progress on this fascinating pathogen. In this book leading international scientists distil exciting findings from this vast body of literature to produce comprehensive and topical reviews on the molecular and cellular biology of H. pylori. The book begins with background chapters covering the history, taxonomy, and epidemiology of H. pylori infection and associated diseases. It continues with chapters on host responses including immunity, apoptosis and animal models followed by chapters on...
	Helicobacter pylori in the 21st Century (Advances in Molecular and Cellular Biology Series) by Philip Sutton (Editor), Hazel M. Mitchell (Editor) Helicobacter pylori is a globally significant pathogen that infects half of the population of the world. Its recognition enabled the development of new therapeutic and preventative strategies for serious health conditions such as gastric cancer, of which it is the major causative agent. Providing a broad overview of the current understanding of this pathogen and emphasising its world health impacts, this book explores a range of topics including virulence factors, vaccine development and obstacles, epidemiology, antibiotic resistance and the role of Nod receptors, with a foreword by Barry Marshall, the Nobel Laureate and co-discoverer of H. pylori. It is an essential resource for researchers, students and medics in infectious and Helicobacter-associated diseases.